Cara Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CARA THERAP, and when can generic versions of CARA THERAP drugs launch?
CARA THERAP has one approved drug.
There are twelve US patents protecting CARA THERAP drugs.
There are forty-five patent family members on CARA THERAP drugs in twenty-five countries and twelve supplementary protection certificates in eleven countries.
Drugs and US Patents for Cara Therap
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 8,236,766 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 9,334,305 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 10,793,596 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Cara Therap Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 5364583 | ⤷ Try a Trial |
Poland | 2064228 | ⤷ Try a Trial |
South Korea | 101513737 | ⤷ Try a Trial |
Israel | 197923 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Cara Therap Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2064228 | C02064228/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: DIFELIKEFALIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68653 16.08.2022 |
2064228 | 2022C/546 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DIFELIKEFALINE SOUS TOUTES LES FORMES COUVERTES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/22/1643 20220427 |
2064228 | 301199 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DIFELIKEFALIN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, HYDRAAT, SOLVAAT, ZUURZOUT-HYDRAAT OF N-OXIDE; REGISTRATION NO/DATE: EU/1/22/1643 20220427 |
2064228 | CR 2022 00045 | Denmark | ⤷ Try a Trial | PRODUCT NAME: DIFELIKEFALIN; REG. NO/DATE: EU/1/22/1643 20220427 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.